1
Mulder, Rene, Lisman, Ton, Meijers, Joost C. M., Huntington, James A., Mulder, Andre B., Meijer, Karina
Veröffentlicht in: Mulder , R , Lisman , T , Meijers , J C M , Huntington , J A , Mulder , A B & Meijer , K 2020 , ' Linkage analysis combined with whole-exome sequencing identifies a novel prothrombin (F2) gene mutation in a Dutch Caucasian family with unexplained thrombosis ' , Haematologica , vol. 105 , no. 7 , pp. E370-E372 . https://doi.org/10.3324/haematol.2019.232504;
2020
Veröffentlicht in: Mulder , R , Lisman , T , Meijers , J C M , Huntington , J A , Mulder , A B & Meijer , K 2020 , ' Linkage analysis combined with whole-exome sequencing identifies a novel prothrombin (F2) gene mutation in a Dutch Caucasian family with unexplained thrombosis ' , Haematologica , vol. 105 , no. 7 , pp. E370-E372 . https://doi.org/10.3324/haematol.2019.232504;
2020
2
3
Seelig, Jaap, Hemels, Martin E. W., Xhaet, Olivier, Bongaerts, Maarten C. M., de Wolf, Axel, Groenemeijer, Bjorn E., Heyse, Alex, Hoogslag, Pieter, Voet, Joeri, Herrman, Jean-Paul R., Vervoort, Geert, Hermans, Walter, Wollaert, Bart, Boersma, Lucas V. A., Hermans, Kurt, Lucassen, Andreas, Verstraete, Stefan, Adriaansen, Henk J., Mairesse, Georges H., Terpstra, Willem F., Faes, Dirk, Pieterse, Mathijs, Virdone, Saverio, Verheugt, Freek W. A., Cools, Frank, ten Cate, Hugo
Veröffentlicht in: Seelig , J , Hemels , M E W , Xhaet , O , Bongaerts , M C M , de Wolf , A , Groenemeijer , B E , Heyse , A , Hoogslag , P , Voet , J , Herrman , J-P R , Vervoort , G , Hermans , W , Wollaert , B , Boersma , L V A , Hermans , K , Lucassen , A , Verstraete , S , Adriaansen , H J , Mairesse , G H , Terpstra , W F , Faes , D , Pieterse , M , Virdone , S , Verheugt , F W A , Cools , F , ten Cate , H & GARFIELD-AF Investigators 2020 , ' Impact of different anticoagulation management strategies on outcomes in atrial fibrillation : Dutch and Belgian results from the GARFIELD-AF registry ' , Journal of Thrombosis and Haemostasis , vol. 18 , no. 12 , pp. 3280-3288 . https://doi.org/10.1111/jth.15081;
2020
Veröffentlicht in: Seelig , J , Hemels , M E W , Xhaet , O , Bongaerts , M C M , de Wolf , A , Groenemeijer , B E , Heyse , A , Hoogslag , P , Voet , J , Herrman , J-P R , Vervoort , G , Hermans , W , Wollaert , B , Boersma , L V A , Hermans , K , Lucassen , A , Verstraete , S , Adriaansen , H J , Mairesse , G H , Terpstra , W F , Faes , D , Pieterse , M , Virdone , S , Verheugt , F W A , Cools , F , ten Cate , H & GARFIELD-AF Investigators 2020 , ' Impact of different anticoagulation management strategies on outcomes in atrial fibrillation : Dutch and Belgian results from the GARFIELD-AF registry ' , Journal of Thrombosis and Haemostasis , vol. 18 , no. 12 , pp. 3280-3288 . https://doi.org/10.1111/jth.15081;
2020
4
5
6
7
de Jong, Lisa A, Dvortsin, Evgeni, Janssen, Kristel J., Postma, Maarten J.
Veröffentlicht in: de Jong , L A , Dvortsin , E , Janssen , K J & Postma , M J 2017 , ' Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands ' , Clinical Therapeutics , vol. 39 , no. 2 , pp. 288-302 . https://doi.org/10.1016/j.clinthera.2016.12.012;
2017
Veröffentlicht in: de Jong , L A , Dvortsin , E , Janssen , K J & Postma , M J 2017 , ' Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands ' , Clinical Therapeutics , vol. 39 , no. 2 , pp. 288-302 . https://doi.org/10.1016/j.clinthera.2016.12.012;
2017
8
Heisen, Marieke, Treur, Maarten J, Heemstra, Harald E, Giesen, Eric B W, Postma, Maarten J
Veröffentlicht in: Heisen , M , Treur , M J , Heemstra , H E , Giesen , E B W & Postma , M J 2017 , ' Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 8 , 0046-RT.R1/1331912 , pp. 813-824 . https://doi.org/10.1080/13696998.2017.1331912;
2017
Veröffentlicht in: Heisen , M , Treur , M J , Heemstra , H E , Giesen , E B W & Postma , M J 2017 , ' Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 8 , 0046-RT.R1/1331912 , pp. 813-824 . https://doi.org/10.1080/13696998.2017.1331912;
2017
9
Kaptein, F H J, Stals, M A M, Grootenboers, M, Braken, S J E, Burggraaf, J L I, van Bussel, B C T, Cannegieter, S C, Ten Cate, H, Endeman, H, Gommers, D A M P J, van Guldener, C, de Jonge, E, Juffermans, N P, Kant, K. M., Kevenaar, M. E., Koster, S, Kroft, L J M, Kruip, M J H A, Leentjens, J, Marechal, C, Soei, Y L, Tjepkema, L, Visser, C, Klok, F A, Huisman, M V
Veröffentlicht in: Kaptein , F H J , Stals , M A M , Grootenboers , M , Braken , S J E , Burggraaf , J L I , van Bussel , B C T , Cannegieter , S C , Ten Cate , H , Endeman , H , Gommers , D A M P J , van Guldener , C , de Jonge , E , Juffermans , N P , Kant , K M , Kevenaar , M E , Koster , S , Kroft , L J M , Kruip , M J H A , Leentjens , J , Marechal , C , Soei , Y L , Tjepkema , L , Visser , C , Klok , F A , Huisman , M V & Dutch COVID & Thrombosis Coalition 2021 , ' Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave ' , Thrombosis Research , vol. 199 , pp. 143-148 . https://doi.org/10.1016/j.thromres.2020.12.019;
2021
Veröffentlicht in: Kaptein , F H J , Stals , M A M , Grootenboers , M , Braken , S J E , Burggraaf , J L I , van Bussel , B C T , Cannegieter , S C , Ten Cate , H , Endeman , H , Gommers , D A M P J , van Guldener , C , de Jonge , E , Juffermans , N P , Kant , K M , Kevenaar , M E , Koster , S , Kroft , L J M , Kruip , M J H A , Leentjens , J , Marechal , C , Soei , Y L , Tjepkema , L , Visser , C , Klok , F A , Huisman , M V & Dutch COVID & Thrombosis Coalition 2021 , ' Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave ' , Thrombosis Research , vol. 199 , pp. 143-148 . https://doi.org/10.1016/j.thromres.2020.12.019;
2021
10
De Jong, Lisa A., Gout-Zwart, Judith J., Stevanovic, Jelena, Rila, Harrie, Koops, Mike, Huisman, Menno V., Postma, Maarten J.
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018